Harvard Bioscience, Inc. (HBIO) Misses Q4 EPS by 2c
Tweet Send to a FriendGet Alerts HBIO Hot Sheet
Price: $4.92 -2.77%
Revenue Growth %: -7.8%
Financial Fact:
Gross Profit: 12.27M
Today's EPS Names:
CIDM, ATU, CRWS, More
Revenue Growth %: -7.8%
Financial Fact:
Gross Profit: 12.27M
Today's EPS Names:
CIDM, ATU, CRWS, More
Trade HBIO Now!
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $29.2 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- China Cord Blood Corp. (CO) Tops Q4 EPS by 3c
- Cinedigm Digital Cinema (CIDM) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
